###begin article-title 0
Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 606 645 606 645 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oxfordjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 2
###begin p 3
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 468 476 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 847 851 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1196 1200 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1321 1325 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
CFTR expression is tightly controlled by a complex network of ubiquitous and tissue-specific cis-elements and trans-factors. To better understand mechanisms that regulate transcription of CFTR, we examined transcription factors that specifically bind a CFTR CArG-like motif we have previously shown to modulate CFTR expression. Gel mobility shift assays and chromatin immunoprecipitation analyses demonstrated the CFTR CArG-like motif binds serum response factor both in vitro and in vivo. Transient co-transfections with various SRF expression vector, including dominant-negative forms and small interfering RNA, demonstrated that SRF significantly increases CFTR transcriptional activity in bronchial epithelial cells. Mutagenesis studies suggested that in addition to SRF other co-factors, such as Yin Yang 1 (YY1) previously shown to bind the CFTR promoter, are potentially involved in the CFTR regulation. Here, we show that functional interplay between SRF and YY1 might provide interesting perspectives to further characterize the underlying molecular mechanism of the basal CFTR transcriptional activity. Furthermore, the identification of multiple CArG binding sites in highly conserved CFTR untranslated regions, which form specific SRF complexes, provides direct evidence for a considerable role of SRF in the CFTR transcriptional regulation into specialized epithelial lung cells.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) gene occurs in a subset of specialized cells of epithelial origin (1-3) and is tightly regulated both temporally and spatially (4,5). However, no clear mechanism responsible for this regulation has yet been reported in part due to the complexity of the non-coding regions structure of the CFTR gene.
###end p 5
###begin p 6
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 760 762 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 765 769 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 892 895 884 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cut</italic>
###xml 907 909 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 607 612 <span type="species:ncbi:9606">human</span>
Despite the absence of a TATA element, the transcription of the CFTR gene may be initiated through several discrete start sites (6,7), including those that are tissue-specific (8). An intact CCAAT consensus is also required for accurate transcript initiation (9). Both basal and cAMP-mediated regulation of CFTR transcription involve a weak cAMP response element (CRE) nucleotide consensus (10,11) in tandem with a consensus inverted CCAAT element or Y box (9). In addition, CFTR transcription may be modulated by additional overlapping cis-acting elements, including a polymorphic YY1 site, located in the human minimal CFTR promoter (12). CFTR promoter activity may be enhanced by exogenous transfected NF-kappaB via its binding to the -1103 kappaB element (13). CFTR expression is also regulated through interactions with factors involved in remodeling of chromatin structure, such as CDP/cut and hGCN5 (14).
###end p 6
###begin p 7
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 538 542 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 630 634 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Because none of these cis-acting elements confers tissue-specific control of CFTR expression, several studies focused on identifying potential regulatory elements that lie mainly outside the coding region. Extensive analyses of the chromatin structure identified multiple clusters of DNase I-hypersensitive sites (DHSs) (15,16), some of which contain tissue-specific enhancer elements (17,18). Multiple binding sites for a tissue-specific transcription factor, called HNF1alpha, recently identified in various DHS core, modulate likewise CFTR expression (19). Despite extensive studies, the transcriptional regulatory networks of CFTR expression remain to be unraveled.
###end p 7
###begin p 8
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 1004 1014 1004 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1415 1420 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1505 1509 1505 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1784 1792 1784 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1797 1804 1797 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1810 1814 1810 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1991 1995 1991 1995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2029 2033 2029 2033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2237 2239 2237 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 2240 2242 2240 2242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 2289 2293 2289 2293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2401 2410 2401 2410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 2557 2561 2557 2561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2659 2663 2659 2663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2727 2731 2727 2731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2896 2900 2896 2900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
###xml 1004 1014 <span type="species:ncbi:7227">Drosophila</span>
Our current model for the regulation of human CFTR expression proposes that multiple transcription factors interact with previously reported polymorphic and composite cis-acting elements encompassing a CArG-like motif (12,20). The CArG box (CC(A/T)6GG), originally defined as the core component of the serum response element (SRE), is found in the 5' region of immediate early response genes, such as c-fos (21), and in many muscle-specific gene promoters (22). This DNA element binds serum response factor (SRF), highly regulated and interactive transcription factor, which is phylogenetically conserved and belongs to the MADS box family of proteins, with MCM1, Agamous, Deficiens and SRF (23). Although SRF is particularly enriched in skeletal, cardiac and smooth muscle lineages (24,25), it is also expressed in a variety of human cell lines from distinct tissue origins (26), and, to a lesser extent, in ectoderm-derived tissue such as gastric epithelium (27). Interestingly, it has been shown that Drosophila SRF homolog is expressed in a subset of tracheal cells and regulates cytoplasmic outgrowth during terminal branching of the tracheal system (28). Hence, it has been suggested that SRF plays an essential role in the formation of the respiratory system. Moreover, it has been recently shown that SRF is involved in myofibroblast differentiation during lung damage (29). Therefore, we hypothesized that trans-acting factors interacting with CArG-like motif, such as SRF, could be important in CFTR expression regulation. We provided evidence that SRF is expressed in bronchial epithelial cell expressing endogenous CFTR protein. Through the use of combined gel mobility shift-chromatin immunoprecipitation (ChIP) assays, we first demonstrated that SRF protein binds, both in vitro and in vivo, the CFTR minimal promoter region spanning the CArG-like motif. Mutagenic studies and transient co-transfections experiments showed that SRF alone is not sufficient to transactivate the CFTR gene. Upon some mutations of the CFTR-CArG-like element, promoter activity is severely decreased, potentially implying YY1 as a co-repressor. Given the YY1 well-defined role in the transcriptional regulation of some SRE-dependent promoters (30-33), we explored the putative role of YY1 on the CFTR promoter activity and demonstrated functional interplay between this factor and SRF. Finally, by stringent in silico structural analysis, we identified additional multiple near consensus CArG sites within the highly conserved promoter and intronic regions of the CFTR gene. We also documented the existence of SRF-containing protein complexes on numerous predicted CFTR CArG-like elements. Taken together, the data obtained classify CFTR as a novel SRF target gene, subject to modest but significant SRF activation, and open the gate to further investigate how SRF may be involved in the regulation of CFTR gene expression.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cell culture
###end title 10
###begin p 11
###xml 265 266 265 266 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 374 375 374 375 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 457 458 457 458 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 515 517 515 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 542 544 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 600 601 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 770 772 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 773 775 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 870 872 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 873 875 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 328 334 <span type="species:ncbi:9913">bovine</span>
Human bronchial epithelial cells, Beas2B and A549 expressing endogenous CFTR were kindly provided by Dr Marc Chanson, Department of Pediatrics, Laboratory of Clinical Investigation, Switzerland. Beas2B and A549 cells were maintained in high glucose DMEM (4500 mg/l d-Glucose, Invitrogen Corporation) supplemented with 10% fetal bovine serum (FBS) (Eurobio, France) and 5 mM l-glutamine. C2C12 myoblasts were grown in DMEM supplemented with 10% FBS and 5 mM l-glutamine. All cell cultures, supplemented with 100 U ml-1 penicillin and 100 mg ml-1 streptomycin, were maintained at 37degreesC under 5% CO2. As positive or negative controls for the different assays, other cells used in this study included colon adenocarcinoma Caco-2 cell line (ECACC) with functional CFTR (34,35) and normal monkey kidney fibroblast-like COS-7 cell line (ATCC) which does not express CFTR (36,37); all were maintained in DMEM supplemented with FBS and were incubated in the same conditions as above.
###end p 11
###begin title 12
Plasmids constructs
###end title 12
###begin p 13
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 636 643 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 853 861 844 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1546 1553 1537 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1649 1652 1632 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 1049 1054 <span type="species:ncbi:9606">human</span>
###xml 1754 1759 <span type="species:ncbi:9606">human</span>
###xml 1806 1811 <span type="species:ncbi:9606">human</span>
The original luciferase expression vector pGL3-Basic containing the wild-type human CFTR minimal promoter was described previously (12). To further study the putative composite cis-acting element located at -108 from the major transcription initiation site of the human CFTR promoter (38), the CFTR-CArG-like motif was either mutated in a consensus CArG box or in a degenerated motif. Mutations were introduced into the WT-pGL3 plasmid using an oligonucleotide-directed mutagenesis system (QuickChangetrade markSite-Directed Mutagenesis Kit, Stratagene) according to the manufacturer's instructions. Mutagenesis primers are depicted in Table 1. The presence of mutations and sequence fidelity were verified by dideoxynucleotide sequencing. For each introduced mutation the loss or the improvement of transcription factor binding activity was checked by in vitro assays. The 3xSRE-fos TATA-luciferase reporter construct was kindly provided by R. A. Hipskind, Institut de Genetique Moleculaire, Montpellier, France. Expression vectors encoding either human wild-type SRF, the pHiv-SRF or SRF dominant-negative form deleted of an essential part of DNA-binding domain (DBD), the pHiv-DN, were generously given by D. Trouche, Laboratoire de Biologie Moleculaire Eucaryote, Toulouse, France. Another dominant-negative SRF mutant, pHiv-DBD, was constructed by PCR amplification of SRF fragment spanning the DBD flanked by HindIII and HincII sites to facilitate cloning into expression vector. The PCR was performed using pHiv-DBD-SRF primers (listed in Table 1), 10 ng of SRF expression vector, 200 microM of each dNTP, 0.5 microM of each primer and 1.5 U Taq DNA polymerase (Perkin Elmer, Inc.) in a 1x reaction buffer provided by the manufacturer. TranSilent human control siRNA vector and TranSilenttrade mark human SRF siRNA vector (catalog no. SR1038) were purchased from Panomics. Expression vectors encoding either pCMV-YY1 or pcDNA3-YY1 were generously provided by E. Seto, E. Bonnefoy and A. Moustakas, respectively.
###end p 13
###begin title 14
Transient transfections
###end title 14
###begin p 15
###xml 100 103 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 197 200 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 422 429 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 719 721 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 885 892 873 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1577 1581 1551 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 406 410 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Cells were seeded at a density of 200 000 cells/2 ml of medium and plated in 6-well dishes (NUNClone(R), Merck-Eurolab, Inc.). After a culturing period of 24 h, cells were transfected with PolyFect(R) transfection reagent (Qiagen Corporation, France) according to the manufacturer's recommendations. For transient transfection, we used 1.8 microg of plasmid reporter and 0.2 microg of internal control pRL-SV40 containing Renilla luciferase (Promega Corporation). The pGL3-Basic vector lacking both eukaryotic promoter and enhancer sequences was used as a negative control. After 48 h, the luciferase activity was evaluated with the Dual Luciferase Reporter Assay System (Promega Corporation), as described previously (12). Luminescence measurements were performed on a Luminoskan Ascent luminometer (ThermoLabsystem Corporation, France). Firefly luciferase activity was normalized to Renilla luciferase activity. All luciferase activities represent at least three independent experiments with each construct tested in triplicate per experiment. Luciferase activity data are expressed as the means +/- SD computed from the results obtained from each set of transfection experiments. To minimize the possibility of errors in DNA amplification, at least two independently constructed clones were tested. For co-transfection assays, unless otherwise indicated, 1.8 microgof luciferase reporter and 1-2 microg of each expression vector were used. Transfection with siRNA was performed using Lipofectamine 2000 (Invitrogen) with 2.5 microg of siRNA. The cells were transfected with CFTR promoter plasmid reporter, and luciferase activity was determined as described above. Aliquots of cell lysates were used for western blotting to confirm the specificity and level of SRF protein knockdown.
###end p 15
###begin title 16
Preparation of whole cell proteins, nuclear extracts and recombinant protein production
###end title 16
###begin p 17
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 899 915 891 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 941 943 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 899 915 <span type="species:ncbi:562">Escherichia coli</span>
For the CFTR immunodetection analyses, Beas2B, A549, C2C12, COS-7 and Caco-2 cells were treated with 5 mM sodium phenylbutyrate, which has been previously reported to increase CFTR (39) and scraped into lysis buffer (50 mM Tris-HCl, 1% NP-40, 40 mM beta-glycerophosphate and 120 mM NaCl) supplemented with protease inhibitors [1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM DTT, and 1 microg/microl aprotinin, leupeptin and pepstatin]. Nuclear extracts were prepared using the Nuclear extraction kit according to the procedure recommended by the supplier (Panomics, Ozyme, France). Protein concentrations were determined using the Bio-Rad Protein Assay kit with BSA as a standard, based on the classical Bradford method. The pGEX-SRF plasmid, a generous gift from D. Trouche (Laboratoire de Biologie Moleculaire Eucaryote), was used for protein expression. GST-SRF fusion protein was purified from Escherichia coli as described previously (40). The purity and concentration of protein samples were estimated by SDS-PAGE.
###end p 17
###begin title 18
Electrophoretic mobility shift assay (EMSA) and supershifts
###end title 18
###begin p 19
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 222 229 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 350 352 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 411 413 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 973 980 941 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1032 1039 1000 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
Oligonucleotides probes were synthesized corresponding to CFTR CArG-like element and mutant versions in which the CArG motif was either mutated in a consensus box or disrupted. The oligonucleotide sequences were listed in Table 2. Single-stranded complementary oligonucleotides containing the studied sequences were annealed, end-labeled with [gamma-32P]ATP (5000 Ci/mmol) and purified as described previously (12). Mobility assay conditions were specifically optimized for binding of SRF. The binding reaction was carried out in a total volume of 20 microl containing 2 ng (approximately30 000 c.p.m.) of the labeled probe, 10 microl of binding buffer (2x), 0.25 microg poly(dI-dC) (Amersham Pharmacia) used as a non-specific competitor, 5-12 microg of nuclear extracts and 100-1000 ng of GST-SRF fusion chimera protein. For EMSA competition and antibody interference assays, proteins were incubated with either cold specific competitors (WT and SRE oligonucleotides, see Table 2), unspecific competitor (GATA oligonucleotide, see Table 2) or purified antibodies (anti-SRF: sc-335X; anti-YY1: sc-1703X or anti-HA, Santa Cruz, Biotechnology Inc., TEBU, France) for 20 min before addition of labeled probes. After incubation of 30 min at room temperature, complexes were resolved on 5% acrylamide:bisacrylamide (29:1) native gel containing 0.5x TBE at 26 mA for 1 h.
###end p 19
###begin title 20
Formaldehyde cross-linking and chromatin immunoprecipitation
###end title 20
###begin p 21
###xml 2053 2057 1987 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2278 2285 2206 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 2047 2052 <span type="species:ncbi:9606">human</span>
Beas2B and A549 cells proteins were cross-linked to DNA by adding formaldehyde to a final concentration of 1% for 10 min at 37degreesC. The fixed cells were prepared for immunoprecipitation using the protocol of ChIP assay kit (Upstate Biotechnology Inc., Euromedex, France) with minor modifications. Cells were resuspended in 1 ml cold phosphate-buffered saline (PBS), pelleted by centrifugation and lysed in 800 microl of SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) containing protease inhibitors (1 mM PMSF, 1 microg/mlaprotinin and 1 microg/ml pepstatinA). After incubation on ice for 10 min, the cross-linked chromatin was sheared by sonication at the following conditions eight times for 10 s at 40% of maximum power and diluted 10-fold in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1 and 167 mM NaCl) with protease inhibitors. Aliquots containing 20 microl of each aliquot were used as a control to show total input DNA. The chromatin solution was precleared with 80 microl of salmon sperm DNA/protein A agarose-50% slurry (Upstate Biotechnology Inc.) for 1 h at 4degreesC under agitation, and subsequently incubated at 4degreesC on a rotating stand overnight with either 3 microl of anti-SRF antibody (sc-335X, Santa Cruz, Biotechnology Inc.) or an irrelevant antibody (anti-HA). Immune complexes were precipitated by the addition of 60 microl of salmon sperm DNA/protein A agarose and incubated at 4degreesC for 1 h and low speed spinning. Precipitates were washed once with 1 ml of low salt buffer, once with high salt buffer, once with LiCl buffer and twice with 1x TE, according to the manufacturer's recommendations (Upstate Biotechnology Inc.). The cross-links were reversed by the addition of 20 microl of 5 M NaCl and incubation at 65degreesC overnight. The samples were treated with proteinase K, phenol-chloroform extracted, ethanol precipitated and resuspended in 30 microl of sterile water. PCR analysis was carried out using primers from different regions of the human CFTR promoter and as additional controls from promoter regions of a number of genes that are either silent (beta-globin) or having at least one functional CArG element (beta-actin). The sequences of PCR primers are listed in Table 1. After 45 cycles of amplification, PCR products were separated on 1.8% agarose gels and visualized by ethidium bromide staining and UV transillumination.
###end p 21
###begin title 22
Reverse transcriptase-PCR
###end title 22
###begin p 23
###xml 145 148 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 624 625 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 981 984 937 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 1042 1081 998 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hypoxanthine PhosphoRybosyl-Transferase</italic>
###xml 1083 1087 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1174 1177 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 1213 1217 1169 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1579 1583 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1623 1625 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1801 1804 1729 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 1809 1813 1737 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2061 2063 1989 1991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 2064 2066 1992 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
Total RNA from epithelial cells (Beas2B and A549), myoblasts (C2C12) and fibroblasts (COS-7) was isolated using the SV Total RNA Isolation System(R) (Promega, France). Reverse transcription was performed with 3 microg of total RNA, 300 ng of random hexamers (Invitrogen Corporation), 10 mM dNTPs, 1 microl of RNasin RNase inhibitor (Promega), 2 microl of DTT at 0.1 M, 4 microl of first strand buffer (Invitrogen), 200 U of M-MLV RT (Invitrogen) and nuclease-free water (Promega) in a final reaction volume of 20 microl. For each RNA template, a control reaction without RT was included. For each RT reaction condition, an H2O no-template reaction was included as an additional negative control. The reaction mixture was incubated first for 10 min at 25degreesC, then 40 min at 42degreesC; this was followed by a heat inactivation step of 72degreesC for 3 min. Aliquots containing 1 microl of the cDNA synthesis reaction mixture were used for PCR analyses. The expression level of SRF mRNA was analyzed by PCR amplification of the endogenous Hypoxanthine PhosphoRybosyl-Transferase (HPRT) gene used as internal control. Amplification mixture included either 10 pmol of each SRF-specific primer or 10 pmol of each HPRT-specific primer, 1.5 U of AmpliTaq polymerase (Applied Biosystem Corporation) and nuclease-free water (Promega) in a 25 microl volume. Amplification was performed with an initial denaturation step at 95degreesC for 5 min, followed by 35 cycles of 30 s of 95degreesC denaturation, 60 s of 52degreesC annealing and 2 min extension at 72degreesC. Amplification of CFTR was performed as described previously (41). The RT-PCR products were separated on an 8% non-denaturing polyacrylamide gel, stained with ethidium bromide. To ensure that the sequence of cDNA products derived from both SRF and CFTR RT-PCR analyses correspond to respective published sequences, the cDNA bands were purified and prepared for dideoxy DNA sequencing. Controls included RNA preparations from monkey kidney fibroblasts (COS-7), which are negative for CFTR expression (36,37).
###end p 23
###begin title 24
Western blot analysis
###end title 24
###begin p 25
###xml 785 796 <span type="species:ncbi:3704">horseradish</span>
Twenty-five microgram protein extracts (except where otherwise indicated) were resolved on a 10% (except where otherwise indicated) SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane (except where otherwise indicated). All membranes were Ponceau S stained to ensure sample integrity. Briefly, the membranes were blocked with 5% skim milk in PBS supplemented with 0.01% Tween-20 and incubated with diluted primary antibodies in 5% skim milk (1:5000 diluted anti-SRF Abs: sc-335X and sc-25290X purchased from Santa Cruz; 1:1000 diluted anti-CFTR Ab: 24.1 from R&D System; 1:2500 diluted anti-beta-actin antibody: AC-15 from Sigma, 1:2500 diluted anti-beta-tubulin antibody: T6074 from Sigma) overnight. The membranes were then washed and incubated with an appropriate horseradish peroxidase (HRP) conjugated secondary antibody at 1:15 000 in PBS-5% milk. The membranes were reacted with chemiluminescence reagent ECL (Roche Diagnostic) as described by the manufacturer and subsequently exposed to Biomax photographic film (Kodak Corporation). The protein levels of the actin housekeeping gene (except where otherwise stated) were assayed for internal control of protein loading.
###end p 25
###begin title 26
Indirect immunofluorescence
###end title 26
###begin p 27
###xml 617 619 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 774 776 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 777 779 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 852 854 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 855 857 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 581 586 <span type="species:ncbi:9606">human</span>
###xml 588 591 <span type="species:ncbi:10116">rat</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 603 609 <span type="species:ncbi:9913">bovine</span>
###xml 828 833 <span type="species:ncbi:9606">human</span>
###xml 1020 1026 <span type="species:ncbi:9793">donkey</span>
###xml 1032 1038 <span type="species:ncbi:9986">rabbit</span>
###xml 1087 1093 <span type="species:ncbi:9793">donkey</span>
###xml 1099 1104 <span type="species:ncbi:10090">mouse</span>
A549, Beas2B, C2C12 and COS-7 cells were plated on Lab-Tektrade markII CC2trade mark Chamber Slidetrade mark systems (Nalge Nunc) 1 day before immunohistochemical analysis. The cells were fixed and permeabilized in 4% paraformaldehyde and 0.1% Triton X-100, respectively, for 20 min durations at room temperature. Non-specific binding sites were blocked with 1% BSA in PBS for 1 h. The cells were subsequently incubated with primary antibodies diluted in 1:100 in PBS-BSA. Antibodies used included, the clone L12B4 (Upstate biotechnology), an anti-CFTR antibody known to recognize human, rat, mouse and bovine CFTRs (42) and the H-300 or the A11 anti-SRF antibody (sc-13029 and sc-25290, Santa Cruz). The specificity of the anti-CFTR antibody has been described previously (43,44) and was also verified by using a CFTR-positive human Caco-2 cell line (34,35). For nuclear counterstaining, DAPI (sc-3598, Santa Cruz) was applied at a concentration of 1:5000. Cells were then washed with PBS-BSA and incubated with either donkey anti-rabbit fluorescein isothiocyanate-conjugated (FITC) or donkey anti-mouse Cy3trade mark conjugated secondary antibody (Jackson ImmunoResearch Laboratory Inc.) diluted 1:200 for 1 h at room temperature. Cells were washed twice with PBS-BSA, once with PBS, and mounted with Dakocytomation fluorescent mounting medium (Dakocytomation). Indirect immunofluorescence was examined with an inverted Leica DMR microscope (Leica Microsystemes SAS). Final images were further processed using Adobe Photoshop 7.0 software.
###end p 27
###begin title 28
Statistical analyses
###end title 28
###begin p 29
###xml 97 98 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 155 156 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 351 353 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL</sup>
###xml 576 580 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
Transfection data are expressed as the mean +/- SE. Paired comparisons were made using student's t-test. Data were considered statistically significant at P < 0.05. All graphical data and statistical analyses were generated with GraphPAD Prism software (Version 3.0). Densitometric analysis was performed using computerized densitometry and ImageQuantTL v.3.0 software (Amersham Biosciences). Densitometric values for both transcript and protein bands were determined in areas of equal size and are reported in normalized arbitrary units relatives to the expression of either HPRT gene or actin protein set to 1 (except where otherwise indicated).
###end p 29
###begin title 30
Computational analyses
###end title 30
###begin p 31
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 194 199 <span type="species:ncbi:9606">human</span>
The computer program ConSite (), particularly suited to the analysis of large genomic sequences, was used to identify putative CArG binding sites within the promoter and intronic regions of the human CFTR gene. The algorithm AliBaba 2.1 () was then used to verify these predictions and minimize false negatives or positives. To prevent a possible bias introduced by palindromic or internally repetitive cis-regulatory elements, overlapping matches, including on opposite DNA strands, were defined as a single match.
###end p 31
###begin p 32
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 182 188 <span type="species:ncbi:9581">gibbon</span>
###xml 207 213 <span type="species:ncbi:9986">rabbit</span>
###xml 215 218 <span type="species:ncbi:9823">pig</span>
###xml 220 225 <span type="species:ncbi:9940">sheep</span>
###xml 230 233 <span type="species:ncbi:9913">cow</span>
To assess the importance of the putative CArG elements identified in the non-coding regions of the human CFTR gene, we performed multiple sequence alignments. The human, cynomolgus, gibbon, squirrel monkey, rabbit, pig, sheep and cow sequences were aligned using the ClustalW global alignment tool () (45). The gap open and extension penalties were set at 15 and 6.66, respectively, and sequence delay divergence of 30% with a DNA transition weight of 0.5 was used.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34
CFTR minimal promoter region encompassing the CFTR-CArG-like element is remarkably conserved
###end title 34
###begin p 35
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 607 616 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 622 626 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 655 656 655 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 662 663 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 738 739 738 739 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 745 746 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 194 199 <span type="species:ncbi:9606">human</span>
To search the cis-acting elements involved in the CFTR gene expression regulation, we previously performed an in silico search for transcription factor binding sites (46), and reported that the human minimal CFTR promoter contains a CArG-like motif, which is localized -108 bp upstream of the major transcription initiation start site (38). Because so far all described CArG-box elements were found in the regulatory regions of immediate early genes (47) and in muscle-specific genes (22), we confirmed our first binding site prediction by using two other algorithms, AliBaba () and ConSite (). As shown in Figure 1A, the CFTR-CArG-like element sequence (GC(A/T)6GG) diverges slightly at the 5' from the published SRF consensus sequence (CC(A/T)6GG) (22,37). However, this divergence is similar to that observed in the smooth muscle-gamma-actin promoter which has been demonstrated to bind SRF (48).
###end p 35
###begin p 36
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 610 619 610 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 865 874 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 917 921 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 749 752 <span type="species:ncbi:9823">pig</span>
###xml 771 776 <span type="species:ncbi:9940">sheep</span>
###xml 778 781 <span type="species:ncbi:9913">cow</span>
###xml 786 792 <span type="species:ncbi:9986">rabbit</span>
To assess the putative functional importance of CFTR-CArG-like binding site, we used an orthogonal approach of deducing regulatory elements by considering orthologous CFTR minimal promoter regions from several mammalian species representing the Primates, Artiodactylia and Lagomorpha orders. Comparison of human/species homologies was carried out using ClustalW multiple CFTR sequence alignments according to the numerous alignment parameters described previously (49). Consistent with previous studies (50,51), we showed that the human minimal CFTR promoter is remarkably conserved across the orders studied (Figure 1B, right panel). We found that the CFTR-CArG-like element is conserved within all the Primates species studied and also within the pig while, within the sheep, cow and rabbit species, some substitutions occur in the middle of the CArG-like motif (Figure 1B). These data are consistent with previous CFTR promoter phylogenetic work that identified two types of regulatory elements: some are conserved between species, such as a non-consensus CRE at positions -0.1 kb relative to ATG and some are species-specific elements, such as a 300 bp purine.pyrimidine (Pu.Py) stretch that is present only in rodents (50).
###end p 36
###begin title 37
Bronchial epithelial expression of SRF
###end title 37
###begin p 38
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 415 454 415 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hypoxanthine PhosphoRybosyl-Transferase</italic>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 512 515 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 607 616 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 737 740 737 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 814 823 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1109 1118 1105 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1220 1223 1216 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 1418 1420 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 1435 1444 1431 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1768 1777 1757 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1935 1944 1924 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 2401 2410 2390 2399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 2553 2562 2542 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 2675 2677 2664 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 2678 2680 2667 2669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 2681 2683 2670 2672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 685 690 <span type="species:ncbi:9606">human</span>
###xml 2731 2736 <span type="species:ncbi:9606">human</span>
Because we could not previously identify SRF binding to the CFTR CArG-like element, even though an anti-SRF antibody had been used (12), we asked whether SRF, mainly described as highly expressed in muscle cells, was also present in epithelial cell lines. To measure the expression levels of SRF mRNAs, we used a RT-PCR-based procedure previously described by Davis et al. (52). As reverse-transcribed control, the Hypoxanthine PhosphoRybosyl-Transferase (HPRT) housekeeping gene was amplified. Amplification of SRF from bronchial epithelial cells and myoblasts yielded a fragment of the same size, 651 bp (Figure 2A), as that of the full-length SRF transcript produced by RT-PCR from human hearts (52). The 453 bp band corresponding to SRF lacking exon 5 (SRFDelta5) was only detected in the C2C12 myoblast line (Figure 2A). To ensure that these bands were not the result of a PCR artifact or genomic contamination of samples, negative controls such as exclusion of RT or RNA during cDNA synthesis were included in each assay. As expected, no PCR product appeared when either RT or the template was omitted (Figure 2A). Densitometric analysis revealed that bronchial epithelial cells contained an appreciable amount of SRF mRNA. Nuclear extracts from A549, Beas2B and C2C12 cells were electrophoresed and then assayed by western blotting with anti-SRF antibody reported to recognize all four isoforms of the protein (52). As shown in Figure 2B, we found that robust expression of a 67 kDa band, that based on molecular mass, corresponds to full-length SRF (SRF-FL) in all of the cell lines examined. Consistent wit RT-PCR analysis, a 57 kDa band corresponding to SRFDelta5 was only detected in the C2C12 myoblast line. As a control, we checked the beta-actin levels (Figure 2B). Densitometric analysis of western blot revealed no apparent difference in the expression level of SRF proteins between the myoblasts and epithelial cells (Figure 2B). In subsequent western blot analyses in which parallel blots were probed with only the secondary antibody, no band was detected (data not shown), thus confirming that these bands are indeed specific for SRF. As further evidence, A549, Beas2B and C2C12 cells express relatively large amounts of SRF, the cell lines were assessed by indirect immunofluorescence labeling. A similar staining pattern was noted in the bronchial epithelial cells and myoblasts (Figure 2C, rows A-C). The nuclei have been stained blue with DAPI. As negative control, no staining was detected when the primary antibody was omitted (Figure 2C, row D). Consistent with other studies reporting that SRF is ubiquitously expressed in a variety of cell types (26,27,53), our SRF expression studies demonstrated that human SRF gene is expressed in bronchial epithelial cells.
###end p 38
###begin title 39
SRF binds the CFTR-CArG-like element
###end title 39
###begin p 40
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 361 363 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 459 466 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 512 521 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 587 596 587 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 1035 1039 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1161 1163 1161 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1193 1202 1193 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1236 1240 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1464 1473 1464 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1529 1538 1529 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 1584 1588 1584 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1790 1799 1790 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 2268 2277 2268 2277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 2457 2462 2457 2462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 2530 2539 2530 2539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 2686 2695 2686 2695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 3098 3107 3098 3107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 3270 3279 3270 3279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 3429 3438 3429 3438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 3513 3518 3513 3518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 3668 3677 3668 3677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 3750 3759 3750 3759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D</xref>
###xml 3871 3875 3871 3875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 4115 4119 4115 4119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 4259 4268 4259 4268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 4594 4598 4594 4598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 766 771 <span type="species:ncbi:9606">human</span>
###xml 4588 4593 <span type="species:ncbi:9606">human</span>
Because the CArG box is not only found in the regulatory regions of many muscle-specific genes but also located at the center of other SREs (54) and forms the core binding site for SRF (55), we have attempted to determine whether or not SRF binds to the CFTR-CArG-like element sequence. We performed two series of bandshift experiments. First, we incubated the 32P-labelLed WT oligonucleotide corresponding to CFTR-CArG-like element sequence (as indicated in Table 2) with bacterially expressed SRF. As shown in Figure 3A (lane 3), EMSA revealed a recombinant SRF-WT duplex. As shown in Figure 3A (lane 5), bands defined as the CFTR-CArG-like-SRF complex disappeared when 100-fold molar excess of specific competitor containing the consensus SRE motif, derived from human c-fos promoter (56), was added. In contrast, competition by an irrelevant oligonucleotide (noted UC) did not appear to significantly alter the complex suggesting specificity of binding (lane 6). To confirm precisely the identity of protein binding in the minimal CFTR promoter (from -121 to -83 bp), bacterially expressed SRF was preincubated with anti-SRF antibody before incubation with 32P-labelled probe. As shown in Figure 3A (lane 4), bands corresponding to CFTR-CArG-like-SRF complex disappeared, and more slowly migrating bands appeared when anti-SRF antibody was added. To verify the antibody specificity, control experiments were performed either in the absence of the SRF protein (Figure 3A, lane 7) or in the presence of an irrelevant antibody (Figure 3A, lane 8). These results demonstrate that the CFTR-CArG-like element is a bona fide SRF-binding site. Second, we performed additional EMSA with the WT oligonucleotide, as main binding target, and nuclear extracts from both epithelial and muscle cells (Figure 3B). While three nucleoprotein complexes were formed from nuclear extracts of Beas2B and C2C12 cells on the WT probe, five complexes were detected from A549 cells. Each nuclear protein complex was designated by an upper case relative to nuclear lysate followed by a Roman numeral indicating its position into the gels. The binding specificity of the different complexes was examined by competition analyses with both specific and non-specific unlabeled oligonucleotides (Figure 3B, lanes 2-4). Although a few non-specific binding activities were observed, complexes BII, BIII, AIII, AV, CI, CII and CIII were efficiently competed with an excess of both WT and c-fos SRE unlabeled specific competitors indicating binding specificity (Figure 3B, lanes 2 and 3, respectively). Control experiments including an irrelevant oligonucleotide did not reveal any change in electrophoretic profiles (Figure 3B, lanes 4). To evaluate whether the SRF protein contributes to the formation of nucleoprotein complexes interacting with the CFTR-derived SRF site, we used a specific antibody against the SRF protein. Although the incubation with the anti-SRF antibody apparently failed to give any discrete supershift from various sources of nuclear proteins, a significant decrease of specific complexes was observed (Figure 3B, lanes 6). This effect seemed to be specific because none of these nuclear protein complexes was supershifted or abolished when a non-specific antibody was used (Figure 3B, lanes 7). Control experiments containing only the anti-SRF antiserum and the radiolabeled WT oligonucleotide did not reveal any binding activities (Figure 3B, lanes 8). In addition, supershift assays performed with the radiolabeled c-fos SRE oligonucleotide instead of the WT probe showed that bands corresponding to SRE-SRF complex disappeared and more slowly migrating bands appeared (Figure 3B, lane 10). The absence of supershift for specific WT binding complexes (Figure 3D, lanes 6) may be explained if the epitope recognized by the anti-SRF antibody is part of (or located near) the CFTR-CArG-like DNA-binding site. Antibody binding would compete DNA binding, resulting in a significant decrease or total disappearance of CArG-like complexes rather than in supershifted complexes. Alternatively, if the interaction between the CFTR-CArG-like DNA-binding site and the SRF protein is insufficiently strong, it could be not as stable as the one observed with the SRE probe (Figure 3B, lane 10) to be detected as a supershift in gel retardation assays. On the one hand, other DNA-binding proteins that are potentially part of this complex could interfere with the antibody's access to SRF protein. Taken together, these EMSA studies establish SRF-binding CArG-like box within the minimal promoter of the human CFTR gene.
###end p 40
###begin title 41
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
SRF binds the CArG-like motif of the CFTR minimal promoter within intact chromatin under physiological conditions
###end title 41
###begin p 42
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 895 902 895 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 921 932 921 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 996 1004 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1027 1037 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 1141 1149 1135 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1295 1303 1289 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1484 1492 1478 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1533 1541 1527 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1698 1702 1692 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1748 1752 1742 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1780 1787 1774 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Although there is extensive evidence that SRF can bind to CArG-like elements in in vitro assays and that it is involved in transcriptional regulation through CArG elements in reporter assays in cultured cells with a typical epithelioid morphology (53), there is a lack of direct evidence for involvement of SRF in transcription of the endogenous CFTR gene within the context of intact chromatin. To directly address whether SRF also binds in vivo, ChIP was carried out in bronchial epithelial cells. For this purpose, DNA-binding proteins of Beas2B epithelial cells were covalently linked to genomic DNA by treatment of the cells with formaldehyde. Cross-linked chromatin was immunoprecipitated with either specific or irrelevant antibodies, anti-SRF and anti-HA, respectively. The precipitated chromatin DNA was then purified and amplified by PCR with specific primers of the target sequences (Table 1). The promoter of beta-globin gene, which lacks CArG elements, was used as negative control (Figure 4, row A). The skeletal beta-actin promoter sequence, which contains at least a consensus SRF-binding site, was used as positive control (Figure 4, row B). As expected, PCR signals were obtained when the DNA/protein adducts were immunoprecipitated with an anti-SRF antibody from both Beas2B (Figure 4, rows B and C, lane 1) and A549 (data not shown) epithelial cell lines. In contrast, the negative controls, in which immunoprecipitation was performed with an irrelevant antibody (Figure 4, rows A-C, lane 3) or without antibody (Figure 4, rows A-C, lane 2), did not show any PCR signal. These results were reproduced in several independently isolated ChIP populations. These data show that the CFTR-CArG-like binding site identified within the CFTR minimal promoter binds SRF in vivo, in bronchial cell lines.
###end p 42
###begin title 43
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human minimal CFTR promoter shows activity in both epithelial and muscular cells
###end title 43
###begin p 44
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 622 626 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">57</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
###xml 983 987 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1121 1125 1121 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1144 1151 1144 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1166 1175 1166 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 1202 1206 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1247 1251 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1477 1481 1477 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1644 1648 1644 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1755 1764 1755 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 1853 1862 1853 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 2293 2302 2293 2302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 2415 2424 2415 2424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 2545 2554 2545 2554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 2628 2637 2628 2637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 2711 2720 2711 2720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 2735 2736 2735 2736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2752 2761 2752 2761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 3209 3213 3209 3213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 3287 3290 3287 3290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 3365 3369 3365 3369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 869 874 <span type="species:ncbi:10090">mouse</span>
###xml 1007 1012 <span type="species:ncbi:10090">mouse</span>
As the SRF transcription factor is thought to mainly mediate the tissue-specific transcription in muscular cells, we first assessed the activity of the minimal CFTR promoter in both epithelial and muscular cell types. We therefore addressed the ability of the WT-pGL3 construct, previously described (12) to drive the expression in Beas2B, A549 and C2C12 cells. As shown in Figure 5A, an efficient transcription of the CFTR promoter could be readily observed in all three cell lines compared with monkey kidney fibroblasts (COS-7), which are negative for CFTR expression (36,37). Surprisingly, the activity of the minimal CFTR promoter in C2C12 cells was 4 to 5.5 times higher than that observed in Beas2B and A549 cells, respectively. Although the expression of the CFTR protein was previously evidenced in some muscle cells (57-59), it has never been investigated in mouse C2C12 myoblasts. Therefore, we investigated the CFTR expression at both mRNA and protein levels. To examine CFTR mRNA expression in mouse myoblasts (C2C12), total RNA isolated from epithelial and non-epithelial cells was analyzed via RT-PCR with CFTR-specific primers (Table 1). As shown in Figure 5B, while no PCR product for CFTR was seen with COS-7 cells, the expected CFTR amplified product was obtained for both epithelial (A549 and Beas2B) and muscular (C2C12) cell lines. No product was detected in the absence of reverse transcriptase or RNA (noted No RT or No RNA, respectively). Although the HPRT PCR control showed non-equivalent amounts of cDNA used in the different PCRs, densitometric analysis revealed that C2C12 cells contained an appreciable amount of CFTR mRNA. Further determination of CFTR expression in C2C12 myoblasts was conducted by western blot analysis (Figure 5C). Caco-2 cells were used as positive control and COS-7 as negative control. As shown in Figure 5C, while mature fully glycosylated band C CFTR was observed in A549, Beas2B and C2C12 cells, the core glycosylated band B CFTR occurred at the same molecular mass only in a subset of cell lines, indicative of potential variations in glycosylation process. To rule out the possibility of antibodies cross-reactivity or non-specific labeling, indirect immunofluorescence analysis was performed with another anti-CFTR antibody, L12B4 (Figure 5D). As expected, the Caco-2 cell line used as a positive control showed strong immunoreactivity for CFTR protein (Figure 5D, row D). In contrast, and as expected, COS-7 cells used as negative control did not stain with this anti-CFTR antibody (Figure 5D, row E). No staining was detected when the primary antibody was omitted (Figure 5D, row F). The comparison of immunofluorescence images between epithelial (Figure 5D, row A, B and D) and muscular (Figure 5D, row C) cells provides evidence that CFTR is significantly expressed in C2C12 myoblasts. However, because the indirect immunofluorescence experiments were performed in permeabilized cells, they do not distinguish between CFTR that is located in the apical membrane and CFTR that is located in a vesicular pool just beneath the apical membrane. These findings, together with the transcriptional activities presented above, suggest that the minimal CFTR promoter might contain tissue-specific enhancer(s) as well as repressive cis-regulatory elements that have the ability to mitigate the activity of the CFTR promoter between epithelial and non-epithelial lineages. Because CF affects mainly epithelial tissues and Beas2B consistently yielded higher enhancer activity than A549, we restricted subsequent studies to this bronchial epithelial cell line.
###end p 44
###begin title 45
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Effects of SRF on the proximal CFTR promoter
###end title 45
###begin p 46
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 498 507 498 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 668 677 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 881 890 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1350 1355 1326 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1596 1605 1548 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1671 1673 1623 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 1856 1858 1796 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 2215 2217 2155 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
###xml 2354 2358 2294 2298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
To assess whether SRF protein might affect CFTR transcriptional regulation, we took two related approaches. First, we co-transfected either exogenous full-length SRF or truncated SRF mutants with the wild-type CFTR minimal promoter. Second, we utilized a siRNA approach to ask whether a reduction in endogenous SRF levels could affect basal CFTR activation. Luciferase assays were carried out in Beas2B cells using the indicated SRF expression vectors and the WT-pGL3luciferase reporter construct (Figure 6B, left panel). The 3XSRE-fos TATA-Luciferase reporter gene was used as positive control because its transcriptional activity is highly dependent on SRF binding (Figure 6B, right panel). As expected, while this synthetic promoter containing several consensus SREs was markedly and significantly activated (>2-fold) by forced expression of full-length SRF protein (pHiv-SRF) (Figure 6B, right panel), truncated SRF mutants either containing only the amino acids 133-264 corresponding to DNA-binding domain of SRF (pHiv-DBD-SRF), or deleted of amino acids 153-165, an essential part for the DNA binding (pHiv-DN-SRF) induced modest but significant decrease of SRE activity (approximately10% and approximately30%, respectively). When these SRF expression vectors were transiently co-transfected with the WT-pGL3 luciferase reporter construct, the trans-activator effect of SRF was notably reduced. Indeed, overexpression of full-length and dominant-negative (pHiv-DN-SRF) SRF proteins resulted in approximately50% increased and approximately30% decreased of luciferase activity, respectively (Figure 6B, left panel). Unexpectedly and inconsistent with previous study (60), the pHiv-DBD-SRF construct induced approximately40% increase of the WT-pGL3 luciferase activity. This results disparity may be explained by the fact that the c-fos promoter study (60) assessed the DBD-SRF domain activity via microinjection of corresponding truncated SRF polypeptide. Perhaps, the best explanation for this increased activity is that the DNA-binding domain of SRF, also called MADS box, is sufficient for transcriptional activation of some SRF-dependent genes because it mediates interactions with accessory co-activators (61). These results suggest that neither of the regions outside the MADS box, N- or C-terminal, appear essential for transactivation of the CFTR promoter by SRF.
###end p 46
###begin p 47
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 123 132 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6C</xref>
###xml 482 491 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6C</xref>
###xml 661 670 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6C</xref>
###xml 769 773 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
To further establish the role of SRF in mediating the increase in CFTR gene transcription, we performed siRNA experiments (Figure 6C). To demonstrate the efficacy of specific SRF siRNA construct, Beas2B cells were co-transfected with either control or SRF siRNA plasmids and western blots were performed to analyze levels of SRF in these cells. Densitometric analysis of western blot showed that endogenous SRF levels were strongly reduced in the presence of the SRF siRNA plasmid (Figure 6C, left panel). Then, control and SRF siRNA plasmids were co-transfected into Beas2B cells with either the WT-pGL3 or the 3XSRE luciferase reporter construct. As shown in Figure 6C (right panel), reduction of endogenous SRF protein level decreased the activity of both wild-type CFTR promoter and 3XSRE-fos TATA-Luciferase reporter constructs by approximately25%.
###end p 47
###begin p 48
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Taken together, these findings indicate that endogenous SRF into bronchial epithelial cells normally function as transcriptional coactivator for the CArG-mediated transactivation. However, we found that SRF activated the CFTR promoter less well than the SRE-containing synthetic promoter, suggesting that the CArG-like element mediated CFTR transcriptional activation probably required other bridging or co-activating factors.
###end p 48
###begin title 49
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 39 44 <span type="species:ncbi:9606">human</span>
The CArG-like element contained in the human minimal CFTR promoter is important but not sufficient for basal transcriptional activity in Beas2B cells
###end title 49
###begin p 50
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 502 509 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 684 693 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 747 756 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 926 935 926 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 1113 1122 1113 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 1148 1152 1148 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1289 1298 1289 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 1667 1676 1667 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 2047 2051 2047 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2144 2148 2144 2148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
To assess the transcriptional relevance of the CArG-like binding sequence of CFTR minimal promoter, mutants were performed to create either more consensus CArG element or degenerated motif (Table 1). We used the D upper-case and the C upper-case to designate the Degenerated CArG motifs and the Consensus CArG elements, respectively. To ensure the efficacy of mutations in abrogating transcription factor binding, we first performed a series of EMSA experiments with each CArG mutant and the WT probe (Table 2). As expected, based on the sequence analysis, the mutations resulting in more degenerated CArG motifs (D1, D2, D3 and D4 mutants) completely abolished SRF-binding activity (Figure 7A, lanes 1-4), when we compared with SRF-WT complexes (Figure 7A, lane 5). In addition, the probes containing more consensus CArG boxes (C1, C2, C3, C4 and C5 mutants) bound SRF more strongly in nuclear extracts prepared from Beas2B (Figure 7A, lanes 6-10). Inclusion of an anti-SRF antibody partially abolished SRF-binding activity and resulted in a slower mobility band, confirming the identity of the binding protein (Figure 7A, lane 11). Then, minimal CFTR promoter constructs bearing the same consensus and disrupted CArG boxes were tested in a transient transfection assays in Beas2B cells (Figure 7B). Compared with luciferase activity resulting from the WT-pGL3 construct, variable increases in reporter activity are observed when D1, D2, D3 and D4 mutant constructs, with disrupted CArG motif, were transiently transfected. On the other hand, mutations that create more consensus CArG element result in either reducing or increasing in the transcriptional activity (Figure 7B). Consistent with the preceding gel-shift results revealing an uncharacterized protein/DNA complex with slightly slower mobility and variable intensity compared with the SRF-DNA complex, these finer mutagenesis studies suggest that both co-activators and co-repressors might interact with the studied promoter sequences. Taken together, these data demonstrated that the CFTR-CArG-like element alone is not sufficient to confer basal transcriptional activation of the CFTR gene.
###end p 50
###begin title 51
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Functional antagonism between SRF and YY1 through competition for the CFTR-CArG-like binding
###end title 51
###begin p 52
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
As a further means of establishing the role for SRF-binding CArG boxes in mediating either the CFTR-enhancer or silencer activity observed with the different minimal CFTR promoter mutants, we performed additional computational analyses. Sequence analysis of CArG boxes and their immediate flanking sequences showed that C1, C3 and C4 constructs contain consensus binding sites for a number of transcription factors, in addition to SRF, including the transcription factor YY1. These findings with previous work (12) have particularly evoked our interest to examine the role of YY1 in SRF-mediated CFTR transcriptional activity.
###end p 52
###begin p 53
###xml 195 204 195 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8A</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
In a first set of experiments, we evaluated whether the YY1 factor contributes to the formation of nucleoprotein complexes interacting with the WT, C1, C3 and C4 radiolabeled probes. As shown in Figure 8A, incubation with specific anti-YY1 antibody resulted in either a significant decrease or total disappearance of some complexes normally formed between the CArG boxes and a component of Beas2B nuclear extracts, establishing DNA binding between YY1 and the sequences tested. As expected, control experiment performed with radiolabeled probe, D2, devoid of any YY1 binding site and the anti-YY1 antiserum did not reveal any change in electrophoretic profiles indicating specificity of the YY1 binding. Thus, these EMSAs demonstrated that the CFTR-CArG-like (WT probe) and more consensus CArG elements (C1 < C3 < C4) served as binding site for at least two distinct nuclear factors, namely SRF and YY1 from bronchial epithelial cells.
###end p 53
###begin p 54
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8B</xref>
Then, to determine whether the interaction of these two factors with their target DNA (CFTR-CArG-like or more consensus CArG sequence) was either mutually inclusive or exclusive, EMSAs were conducted using bacterially expressed SRF and nuclear extracts prepared from Beas2B cells transfected with a YY1 expression vector as a source of YY1 DNA-binding activity. As shown in Figure 8B, the YY1-binding complex was significantly reduced by increasing SRF binding activity, suggesting their mutually exclusive binding to CArG sites.
###end p 54
###begin p 55
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 746 755 746 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8C</xref>
###xml 1066 1070 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1232 1241 1220 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8C</xref>
###xml 1357 1366 1345 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8C</xref>
###xml 1579 1581 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1582 1584 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
Consistent with other studies (32,62), these EMSAs results suggested as a working hypothesis that both SRF and YY1 likely act as functional competitors in the CFTR promoter activity. Since the minimal CFTR promoter is activated by SRF and knowing from previous studies (30-33) that YY1 negatively regulates some promoter containing CArG elements, it seemed logical to first assess whether YY1 could also repress the CFTR promoter. We asked whether CArG-like-binding site in the CFTR promoter acted as negative regulatory elements. Several CFTR promoter reporter constructs containing either CArG-like (namely, WT) or consensus CArG element (C1, C3 and C4) were co-transfected with SRF and/or YY1 expression vectors into Beas2B cells. As shown in Figure 8C, while co-transfections with SRF alone resulted in 1.5- to 2-fold luciferase activation, forced expression of YY1 protein caused a strong decrease in reporter activities (approximately50-75% of the control luciferase value). Therefore, we wanted to determine the functional relationship of both factors in the CFTR activity regulation. Transient co-transfections analysis of combination of protein expression vectors showed that over-expression of SRF either did not restore (Figure 8C, panel with the WT and C4 reporter constructs) or only very slightly raised the YY1-repressed reporter activities (Figure 8C, panel with the C1 and C3 reporter constructs). These findings are consistent with results obtained from co-transfections performed with the YY1 expression vector alone and previous alpha-actin promoter studies (30-33), in which YY1 acted as a strong repressor. Taken together, these data suggested functional antagonism between SRF and YY1 through DNA-binding competition.
###end p 55
###begin title 56
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Identification of multiple CArG binding sites in the non-coding regions of the human CFTR gene and assessment of their putative functional importance
###end title 56
###begin p 57
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 106 115 106 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 401 410 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9A</xref>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b63">63</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 602 605 <span type="species:ncbi:9913">cow</span>
To assess the putative importance of CArG motifs in the human CFTR expression regulation, we performed an in silico inspection of additional sequences upstream of the minimal promoter and in the intronic regions. Four CArG binding sites were found in the CFTR promoter regions, and seven in the intronic regions. The distribution and the positions of these putative binding sites for SRF are shown in Figure 9A. Then, to confirm the computational predictions, we used several approaches. First, the nucleotide regions harboring these predicted cis-acting elements were analyzed for conservation in the cow, as physiologically relevant transcription factor binding sites are frequently conserved in the non-coding regions of orthologous genes (49,63). Second, the SRF-binding sites were tested by EMSAs and also for one of them by ChIP.
###end p 57
###begin p 58
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 98 107 98 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9B</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 321 330 321 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9C</xref>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 482 491 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9C</xref>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 710 719 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9D</xref>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 866 870 866 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
We showed that all the predicted CArG elements occur in highly conserved CFTR non-coding regions (Figure 9B), which may contain tissue-specific transcription factors (5). We provided evidence that the majority of in silico predicted CArG motifs form specific DNA-protein complexes with bacterially expressed SRF protein (Figure 9C, left panel). We also demonstrated by using Beas2B nuclear extracts and supershift assays that some of these CArG elements bound in vitro SRF protein (Figure 9C, right panel, lanes 1, 3, 7 and 9). Finally, additional ChIP experiments indicated that the only tested CArG element, located at -2373 bp in the CFTR promoter, bound SRF in chromatin from intact cultured Beas2B cells (Figure 9D, lane 1). Collectively, these findings support the concept that SRF may play a key role in the CFTR expression regulation via binding to multiple CFTR CArG elements.
###end p 58
###begin title 59
DISCUSSION
###end title 59
###begin p 60
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 466 471 <span type="species:ncbi:9606">human</span>
While great strides have been made in CFTR research with emphasis on the structure and function of this protein, only incremental advances have been achieved in the field of transcriptional regulation. In our previous works (12,20), we have identified a polymorphic CArG-like site and showed that a naturally occurring sequence variation in this motif may enhance the basal CFTR transcriptional activity. The goal of the present study was to better characterize the human CFTR promoter region encompassing the CArG-like element.
###end p 60
###begin p 61
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">64</xref>
###xml 299 300 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">65</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b68">68</xref>
###xml 1098 1102 1098 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1163 1167 1163 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 405 410 <span type="species:ncbi:9940">sheep</span>
###xml 412 415 <span type="species:ncbi:9913">cow</span>
###xml 420 426 <span type="species:ncbi:9986">rabbit</span>
Comparisons of nucleotide sequences of this CFTR promoter region in eight mammalian species representing three different orders (Primates, Artiodactyla and Lagomorpha) revealed high levels of conservation of the minimal promoter region, as described previously (64). However, the CArG-like element (GC(T/A)6GG), which does not conform to the authentic CArG box (CC(T/A)6GG), is absent from three species (sheep, cow and rabbit). Even though this motif occurs in only a subset of the input sequences, it does not necessarily mean that it is of no functional importance. Instances of cis-regulatory elements being species-specific have been already reported for the CFTR gene (50). More generally, it is well known that some transcription factors can tolerate more than one type of nucleotide at a given position of the binding site. Instances of substitutions in both the central core of the CArG element and the highly conserved contact points for SRF, at the terminal ends, not impairing SRF binding have been previously reported (48,65-68). Taken together, these data support the notion that the CFTR-CArG-like element has possible important implication in the CFTR transcriptional regulation.
###end p 61
###begin p 62
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b69">69</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b70">70</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67">67</xref>
###xml 858 862 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 568 578 <span type="species:ncbi:7227">Drosophila</span>
Interestingly, analysis of SRF expression has revealed relatively high expression levels of SRF protein in the bronchial epithelial cells (Figure 2), as shown in other differentiated epithelial cells (27). Accumulating evidence supports the concept that SRF could contribute to the CFTR expression regulation. In addition to regulating growth-responsive genes and numerous muscle-specific genes (22,69), SRF is also described as a key trans-binding factor in various important physiological events. For example, SRF has been shown to regulate pulmonary development in Drosophila (28), to promote both re-epithelialization and muscular structure restoration during gastric ulcer healing (70) and more recently to be involved in the regulation of endoplasmic reticulum-targeted gene (67). Therefore, it was relevant to examine the potential role of SRF on the CFTR transcriptional activity.
###end p 62
###begin p 63
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 174 183 174 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figures 3</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">4</xref>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">71</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">72</xref>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 939 947 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 1062 1066 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1102 1106 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1236 1244 1236 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
###xml 1335 1339 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1386 1388 1386 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">73</xref>
###xml 1389 1391 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b75">75</xref>
###xml 1472 1476 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1589 1593 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1604 1606 1604 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1661 1663 1661 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1664 1666 1664 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1723 1727 1723 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1861 1865 1861 1865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1958 1967 1958 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8C</xref>
###xml 2075 2079 2075 2079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 2269 2273 2269 2273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
In the present study, we demonstrated that CFTR-CArG-like element forms specific DNA-protein complexes that include SRF protein as part of the complex, in vitro and in vivo (Figures 3 and 4). We have investigated the expression driven by the proximal human CFTR promoter in a pGL3 construct in both epithelial and myoblasts lines. Results of our transient transfections of 3XSRE-fos TATA and WT-pGL3 luciferase reporter genes showed that the human minimal CFTR promoter encompassing a CArG-like motif was sufficient to drive the expression in both cell types (Figure 5). Consistent with other studies showing CFTR expression in smooth muscle tissue (71,72), our results demonstrated that the human CFTR minimal promoter had the ability to drive the expression in muscle lineages. Our transient co-transfections analyses performed with full-length and dominant-negative SRF forms expression vectors, and also specific SRF siRNA constructs (Figure 6, panels B and C) provide the first evidence for a positive role of the SRF protein in the regulation of the human CFTR promoter. However, the SRF-induced CFTR transactivation, though significant, is relatively modest. These data with the results of finer mutagenesis studies presented in Figure 7 support the concept that SRF alone is not sufficient to drive the basal expression of the CFTR gene. As suggested by other previous studies (73-75), it is likely that additional factors might be required to optimally drive the CFTR promoter, as well as to specify the cell-type-restricted expression. Since YY1 was previously shown to bind the CFTR promoter (12) and a subset of SREs serve as binding sites for YY1 (30-33), we first evaluated this candidate in the SRF-mediated CFTR transcriptional activity. The data analysis suggests a functional antagonism between SRF and YY1 through binding competition for the CFTR-CArG-like box. However, the analysis of combinatorial co-transfection studies, presented in Figure 8C, suggests that the functional interplay between SRF and YY1, alone, is not sufficient to account for basal CFTR transcriptional activation. Further studies will be necessary to determine whether another player might be involved in this functional interplay and accounted for the basal transcriptional CFTR activity observed in the Beas2B bronchial epithelial cells.
###end p 63
###begin p 64
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Figure 9</xref>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 349 358 349 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figures 4</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">9D</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">66</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67">67</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b76">76</xref>
###xml 728 730 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 731 733 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b74">74</xref>
###xml 787 791 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 891 895 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1044 1048 1040 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Interestingly, we showed that, in addition to the CArG-like element defined in the minimal promoter of the CFTR gene, there are three CArG motifs located at the 5' end of the gene and seven are present in the intronic regions (Figure 9). We also evidenced SRF binding to CArG elements of the endogenous CFTR gene in the context of intact chromatin (Figures 4 and 9D). Although the role of these more distal CArG boxes has yet to be assessed, these findings are of major importance, since it has been shown that optimal activity of the SRF-dependent target genes may require a number of CArG boxes, including those that are defined in the intronic region (66,67,76). Moreover, as already suggested for the alpha-actin promoters (32,74), perhaps the presence multiple CArG elements in the CFTR gene with cooperative binding events might be essential for SRF to prevent YY1 from binding to the CFTR promoter. Clearly, further studies are needed to directly investigate the role of these multiple CArG elements in transcriptional regulation of the CFTR gene.
###end p 64
###begin p 65
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Taken together, our results demonstrated for the first time that the human CFTR promoter is a novel SRF target gene, subject to modest but significant SRF activation partially due to functional antagonism between YY1 and SRF through mutually exclusive DNA-binding activities of YY1 versus SRF to the CFTR-CArG-like site.
###end p 65
###begin p 66
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig10">Figure 10</xref>
###xml 439 448 439 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig10">Figure 10</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b77">77</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b78">78</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b79">79</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">80</xref>
###xml 1037 1041 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1084 1086 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1099 1100 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1141 1143 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
###xml 1261 1263 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b82">82</xref>
###xml 1502 1504 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b83">83</xref>
###xml 1505 1507 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b84">84</xref>
###xml 1631 1633 1623 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">81</xref>
A critical question is, thus, how might SRF contribute to orchestrating cell-restricted and context-dependent programs of CFTR gene expression? Our findings and investigations to date clearly indicate the presence of several different underlying mechanisms of SRF-dependent transcriptional activation, as represented in Figure 10. These might include association of SRF with a variety of cell-restricted co-factors (noted in gray bubbles, Figure 10), such as MRTF-A highly expressed in epithelial cells of the lung, kidney, colon and testis, and MRTF-B also expressed in smooth muscle cells (77), ternary complex factors, such as p62 and SAP-1 (25,78) and remodeling chromatin co-factors in an HAT-dependent manner, such as the CREB-binding protein (79). In addition, it is well known that binding of SRF to the CArG box induces an acute bend in the DNA and that this bending may vary with changing base compositions across the CArG box (80). Such bending can probably facilitate interactions with other proteins already involved in the CFTR expression regulation, such as NF-kappaB (13) and C/EBP (9) and described as interacting with SRF (81). Finally, the Ras-related GTPases family (rac, RhoA and cdc42) might have a critical role in the activation of SRF (82). Indeed, it is reported that RhoA-induced SRF activation occurs through a phenomenon of 'actin treadmilling' restricted to CArG-dependent genes that do not have adjacent ETS-binding sites (e.g. smooth muscle cell restricted CArG genes) (83,84). Moreover, it has been shown that the activation of SRF may be mediated by the NF-kappaB and C/EBP transcription factors (81).
###end p 66
###begin p 67
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
These data provide the foundation for further studies on the regulation of CFTR and will unable the rational design of further functional studies, including various strategies aiming to further dissect the different regulation pathways.
###end p 67
###begin p 68
This study was supported by grants from both French associations: Vaincre La Mucoviscidose (VLM) and Fondation pour la Recherche Medicale (FRM). J.D. was supported by PhD fellowship grants from the VLM. We are particularly indebted to A. Fernandez and N. Lamb for their continuous support to A.L. and for critical reading of the manuscript and. The authors thank G. Carnac for many valuable discussions and suggestions. The authors also thank the investigators mentioned in Materials and Methods for the kind gifts of crucial reagents. Funding to pay the Open Access publication charges for this article was provided by the Centre National de la Recherche Scientifique (CNRS).
###end p 68
###begin p 69
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin article-title 71
Immunocytochemical localization of the cystic fibrosis gene product CFTR
###end article-title 71
###begin article-title 72
Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia
###end article-title 72
###begin article-title 73
###xml 69 74 <span type="species:ncbi:9606">human</span>
Submucosal glands are the predominant site of CFTR expression in the human bronchus
###end article-title 73
###begin article-title 74
CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents
###end article-title 74
###begin article-title 75
Alternative 5' exons of the CFTR gene show developmental regulation
###end article-title 75
###begin article-title 76
The cystic fibrosis gene has a 'housekeeping'-type promoter and is expressed at low levels in cells of epithelial origin
###end article-title 76
###begin article-title 77
Characterization of the cystic fibrosis transmembrane conductance regulator promoter region. Chromatin context and tissue-specificity
###end article-title 77
###begin article-title 78
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 67 73 <span type="species:ncbi:10090">murine</span>
Tissue-specific in vivo transcription start sites of the human and murine cystic fibrosis genes
###end article-title 78
###begin article-title 79
Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation
###end article-title 79
###begin article-title 80
Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter
###end article-title 80
###begin article-title 81
Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity
###end article-title 81
###begin article-title 82
A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression
###end article-title 82
###begin article-title 83
NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta
###end article-title 83
###begin article-title 84
Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation
###end article-title 84
###begin article-title 85
A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene
###end article-title 85
###begin article-title 86
Multiple potential intragenic regulatory elements in the CFTR gene
###end article-title 86
###begin article-title 87
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
An element in intron 1 of the CFTR gene augments intestinal expression in vivo
###end article-title 87
###begin article-title 88
Evaluation of potential regulatory elements identified as DNase I hypersensitive sites in the CFTR gene
###end article-title 88
###begin article-title 89
HNF1alpha is involved in tissue-specific regulation of CFTR gene expression
###end article-title 89
###begin article-title 90
Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone
###end article-title 90
###begin article-title 91
Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors
###end article-title 91
###begin article-title 92
Serum response factor: toggling between disparate programs of gene expression
###end article-title 92
###begin article-title 93
The MADS-box family of transcription factors
###end article-title 93
###begin article-title 94
The developmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes
###end article-title 94
###begin article-title 95
Serum response factor function and dysfunction in smooth muscle
###end article-title 95
###begin article-title 96
###xml 61 66 <span type="species:ncbi:9606">human</span>
Analysis of SRF, SAP-1 and ELK-1 transcripts and proteins in human cell lines
###end article-title 96
###begin article-title 97
###xml 46 49 <span type="species:ncbi:10116">rat</span>
Expression of serum response factor in normal rat gastric mucosa
###end article-title 97
###begin article-title 98
###xml 28 38 <span type="species:ncbi:7227">Drosophila</span>
The pruned gene encodes the Drosophila serum response factor and regulates cytoplasmic outgrowth during terminal branching of the tracheal system
###end article-title 98
###begin article-title 99
Involvement of serum response factor isoforms in myofibroblast differentiation during bleomycin-induced lung injury
###end article-title 99
###begin article-title 100
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Evolution of cis-acting elements in 5' flanking regions of vertebrate actin genes
###end article-title 100
###begin article-title 101
YY1 facilitates the association of serum response factor with the c-fos serum response element
###end article-title 101
###begin article-title 102
Competition between negative acting YY1 versus positive acting serum response factor and tinman homologue Nkx-2.5 regulates cardiac alpha-actin promoter activity
###end article-title 102
###begin article-title 103
A competitive mechanism of CArG element regulation by YY1 and SRF: implications for assessment of Phox1/MHox transcription factor interactions at CArG elements
###end article-title 103
###begin article-title 104
Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells
###end article-title 104
###begin article-title 105
Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator
###end article-title 105
###begin article-title 106
###xml 69 74 <span type="species:ncbi:9606">human</span>
Characterization of CFTR expression and chloride channel activity in human endothelia
###end article-title 106
###begin article-title 107
Ablation of internalization signals in the carboxyl-terminal tail of the cystic fibrosis transmembrane conductance regulator enhances cell surface expression
###end article-title 107
###begin article-title 108
Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene
###end article-title 108
###begin article-title 109
Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression
###end article-title 109
###begin article-title 110
###xml 26 29 <span type="species:ncbi:9860">Elk</span>
###xml 132 135 <span type="species:ncbi:9860">Elk</span>
The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1
###end article-title 110
###begin article-title 111
Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test
###end article-title 111
###begin article-title 112
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland
###end article-title 112
###begin article-title 113
Antibodies for CFTR studies
###end article-title 113
###begin article-title 114
A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein
###end article-title 114
###begin article-title 115
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice
###end article-title 115
###begin article-title 116
First putative sequence alterations in the minimal CFTR promoter region
###end article-title 116
###begin article-title 117
Primary response genes induced by growth factors and tumor promoters
###end article-title 117
###begin article-title 118
Transforming growth factor-beta induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor
###end article-title 118
###begin article-title 119
Evaluation of gene targeting by homologous recombination in ovine somatic cells
###end article-title 119
###begin article-title 120
Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation
###end article-title 120
###begin article-title 121
###xml 38 41 <span type="species:ncbi:9913">cow</span>
###xml 43 46 <span type="species:ncbi:9823">pig</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
A comparative genomic analysis of the cow, pig, and human CFTR genes identifies potential intronic regulatory elements
###end article-title 121
###begin article-title 122
###xml 82 87 <span type="species:ncbi:9606">human</span>
Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts
###end article-title 122
###begin article-title 123
High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling
###end article-title 123
###begin article-title 124
Expression of the serum response factor gene is regulated by serum response factor binding sites
###end article-title 124
###begin article-title 125
The serum response element
###end article-title 125
###begin article-title 126
Functional antagonism between YY1 and the serum response factor
###end article-title 126
###begin article-title 127
The CFTR chloride channel of mammalian heart
###end article-title 127
###begin article-title 128
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Expression and regulation of chloride channels in neonatal rat cardiomyocytes
###end article-title 128
###begin article-title 129
###xml 143 146 <span type="species:ncbi:10116">rat</span>
Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation
###end article-title 129
###begin article-title 130
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Expression and purification of the DNA-binding domain of SRF: SRF-DB, a part of a DNA-binding protein which can act as a dominant negative mutant in vivo
###end article-title 130
###begin article-title 131
Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain
###end article-title 131
###begin article-title 132
Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1
###end article-title 132
###begin article-title 133
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Human-mouse genome comparisons to locate regulatory sites
###end article-title 133
###begin article-title 134
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Analysis of the mouse and rat CFTR promoter regions
###end article-title 134
###begin article-title 135
Evolutionarily conserved promoter region containing CArG*-like elements is crucial for smooth muscle myosin heavy chain gene expression
###end article-title 135
###begin article-title 136
Serum response factor-dependent regulation of the smooth muscle calponin gene
###end article-title 136
###begin article-title 137
AKAP12alpha, an atypical serum response factor-dependent target gene
###end article-title 137
###begin article-title 138
MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration
###end article-title 138
###begin article-title 139
Journey to the surface of the cell: Fos regulation and the SRE
###end article-title 139
###begin article-title 140
Serum response factor promotes re-pithelialization and muscular structure restoration during gastric ulcer healing
###end article-title 140
###begin article-title 141
###xml 117 120 <span type="species:ncbi:10116">rat</span>
Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic-agonists and VIP in rat smooth muscle cells and its role in vasorelaxation
###end article-title 141
###begin article-title 142
Cardiac expression of the cystic fibrosis transmembrane conductance regulator involves novel exon 1 usage to produce an unique amino-terminal protein
###end article-title 142
###begin article-title 143
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene
###end article-title 143
###begin article-title 144
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Activation of skeletal alpha-actin gene transcription: the cooperative formation of serum response factor-binding complexes over positive cis-acting promoter serum response elements displaces a negative-acting nuclear factor enriched in replicating myoblasts and nonmyogenic cells
###end article-title 144
###begin article-title 145
The avian cardiac alpha-actin promoter is regulated through a pair of complex elements composed of E boxes and serum response elements that bind both positive- and negative-acting factors
###end article-title 145
###begin article-title 146
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions
###end article-title 146
###begin article-title 147
Potentiation of serum response factor activity by a family of myocardin-related transcription factors
###end article-title 147
###begin article-title 148
Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex
###end article-title 148
###begin article-title 149
Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression
###end article-title 149
###begin article-title 150
Structure of serum response factor core bound to DNA
###end article-title 150
###begin article-title 151
Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors
###end article-title 151
###begin article-title 152
The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF
###end article-title 152
###begin article-title 153
Signal-regulated activation of serum response factor is mediated by changes in actin dynamics
###end article-title 153
###begin article-title 154
Differential usage of signal transduction pathways defines two types of serum response factor target gene
###end article-title 154
###begin article-title 155
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins
###end article-title 155
###begin title 156
Figures and Tables
###end title 156
###begin p 157
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 241 242 241 242 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1036 1040 1036 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1139 1143 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 313 318 <span type="species:ncbi:9606">human</span>
###xml 387 393 <span type="species:ncbi:9581">Gibbon</span>
###xml 412 418 <span type="species:ncbi:9986">Rabbit</span>
###xml 420 423 <span type="species:ncbi:9823">Pig</span>
###xml 425 430 <span type="species:ncbi:9940">Sheep</span>
###xml 435 438 <span type="species:ncbi:9913">Cow</span>
###xml 756 761 <span type="species:ncbi:9606">human</span>
###xml 967 972 <span type="species:ncbi:9606">human</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
Cross-species comparison of the CFTR-CArG-like element. (A) Visualization of consensus CArG binding site: pop-up window containing information about SRF transcription factor obtained from in silico analysis performed with the ConSite tool. (B) Detailed alignment view of the CArG-like element-including region of human CFTR minimal promoter with seven orthologous sequences: Cynomolgus, Gibbon, Squirrel Monkey, Rabbit, Pig, Sheep and Cow. Dashes indicate gaps that were introduced to maximize alignment. Each sequence is represented by a classical text representation with each nucleotide assigned its own color (A is colored in red, C in blue, G in green and T in black). The numberings above the Cynomolgus sequence are indicated according to the major human transcription initiation site. In the left panel, the phylogenetic relationships between the different species are illustrated in a rooted tree, directly derived from ClustalW program. In the right panel, human/species homologies are indicated. The accession number of each CFTR genomic sequence is indicated below each species name, in brackets and bold characters. The human CFTR-CArG-like motif is noted above the Cynomolgus sequence.
###end p 157
###begin p 158
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRF</italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 589 590 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 730 731 730 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1286 1287 1273 1274 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Bronchial epithelial expression of SRF. (A) Detection of SRF and HPRT transcripts from both bronchial epithelial and myoblast cell lines by RT-PCR analysis. Total RNAs isolated from A549, Beas2B and C2C12 cells, as indicated, were reverse transcribed with random hexamers and PCR amplified with SRF or HPRT primers. Amplified products were directly stained with bromide ethidium on non-denaturing polyacrylamide gel. Expected size of PCR products is given at left of each transcript. Negative controls are noted as follow: No RT for the absence of reverse transcriptase and No RNA for an H2O no-template reaction. Densitometric analysis of SRF bands intensity was performed with relative HPRT mRNA expression in C2C12 myoblasts. (B) Western blot analysis of nuclear extracts prepared from both epithelial and myoblast lines. Each extract (25 microg) was separated by SDS/PAGE (10%) and western blotted using an anti-SRF Ab. Relative mass, in kilodaltons, is indicated alongside. As a control for proteins loading in SDS-PAGE, an anti beta-actin Ab was used in western blot. Numbers below the beta-actin panel indicate densitometric values of the total SRF bands normalized over the corresponding beta-actin bands and expressed relative to the C2C12 controls bands, which are set to 1. (C) The A549, Beas2B and C2C12 cells (rows A, B and C, respectively) were grown on coverslips, fixed and subjected to indirect immunofluorescence with anti-SRF Ab. Left panel, cells were stained with FITC-conjugated secondary antibody (green). Middle panel, cells were counterstained with DAPI (blue) for nuclear staining. Right panel, shown is merge of SRF immunostaining and DAPI. Row D, background immunofluorescence obtained in the absence of the primary antibody.
###end p 158
###begin p 159
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UC</italic>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 876 877 876 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 908 910 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1460 1462 1460 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1677 1682 1677 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
SRF is a component of CFTR-CArG-like binding complexes. (A) EMSAs were performed with a radiolabeled oligonucleotide encompassing the studied CFTR-CArG-like motif (noted WT, see Table 2) and bacterially expressed SRF (lane 3). Competition assays were carried out using a 100-fold molar excess of two specific competitors, noted WT and SRE (lanes 2 and 5, respectively). UC (lane 6) indicates unspecific competitor that is used as negative control. Supershift assays were carried out using either a specific antibody (lane 4) or an irrelevant antibody (lane 8). The arrow SS indicates the Ab-supershifted complex. Neither the retarded nor the supershifted complexes were found when the 32P-labeled WT double-stranded oligonucleotide was incubated either only with the binding buffer (lane 1) or with specific anti-SRF antibody in the absence of purified SRF protein (lane 7). (B) EMSAs were performed with WT 32P-labeled probe in the absence of proteins (lanes 1) or with nuclear extracts (lanes 5) isolated from Beas2B (upper panel), A549 (middle panel) and C2C12 cells (lower panel). Three or five nuclear protein complexes were detected and designated by a cell type-dependent upper-case to the left of autoradiograms. Some binding reaction mixtures included a 100-fold molar excess of the indicated cold probes (lanes 2-4). Immunologic assays were performed with either anti-SRF Ab (lanes 6), or anti-HA as irrelevant antiserum (lanes 7). As a control, the 32P-labeled WT probe was incubated with anti-SRF Ab without nuclear extracts (lanes 8). In additional control experiments, radiolabeled SRE double-stranded oligonucleotide corresponding to the SRE binding site of the c-fos promoter was subjected to EMSAs with nuclear extracts from Beas2B cells (upper panel) in the absence (lane 9) or presence of anti-SRF antiserum (lane 10). Nuclear protein complexes that were significantly decreased or supershifted with anti-SRF Ab are indicated.
###end p 159
###begin p 160
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 473 477 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
ChIP analysis of SRF binding to the endogenous CFTR minimal promoter. Chromatin immunoprecipitation was carried out as described in Materials and Methods. Sheared DNA/protein complexes were immunoprecipitated by using either an anti-SRF Ab or an irrelevant anti-HA Ab. Then, PCR was carried out to detect the endogenous CArG regions in immunoprecipitated chromatin fragments. Target promoter sequences are indicated as follow: row A, beta-globin; row B, beta-actin; row C, CFTR. Lane 1 shows amplification of target sequences in immunoprecipitated chromatin fragments with anti-SRF Ab. Lanes 2 and 3: PCR amplification of control samples, without Ab or with an irrelevant Ab. Lane 4 shows amplification of 1:100 dilution samples of total input DNA for immunoprecipitation.
###end p 160
###begin p 161
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 276 283 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 648 649 638 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 670 674 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 928 929 918 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1042 1046 1032 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1154 1158 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1203 1207 1193 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1263 1264 1253 1254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1918 1919 1902 1903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 260 264 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Analysis of CFTR minimal promoter activity and CFTR expression. (A) CFTR minimal promoter activities in Beas2B, A549, C2C12 and COS-7 cell lines. The amount of 1.8 microg of WT-pGL3 construct was co-transfected together with 0.2 microg of internal control pRL-SV40 containing Renilla luciferase. The empty pGL3-Basic vector was transfected as a negative control. Normalized luciferase values are illustrated as relative light units. The mean of two independent plasmids preps and each experiment with standard errors is shown. The experimental value for luciferase activity represented the mean +/- SD of four separate experiments in triplicates. (B) RT-PCR analysis of CFTR mRNA expression. Total RNA was harvested from the indicated cell lines and subjected to PCR as described in 'Materials and Methods'. cDNA derived from COS-7 was used as a negative control. Samples without reverse transcriptase (noted No RT) or with an H2O no-template reaction (noted No RNA) were used as additional negative controls. Samples were also amplified for HPRT to control for RNA degradation during DNase treatment and reverse transcription. Densitometric analysis of CFTR bands intensity was performed with relative HPRT mRNA expression in Beas2B bronchial epithelial cells. (C) Western blot analysis. Whole cell proteins extracts prepared from indicated cells were subjected to electrophoresis with 7% SDS-PAGE gel and transferred to supported PVDF membrane. CFTR immunoreactivity was detected using 24.1 anti-CFTR Ab as the primary antibody. Positions for the core glycosylated (band B) and mature fully glycosylated CFTR (band C) are indicated by the arrows at the right. Numbers below the beta-actin panel indicate intensity values of integrated optical densities of the mature and immature CFTR bands normalized over the corresponding beta-actin bands and expressed relative to the Beas2B controls bands, which are set to 1. (D) Indirect immunofluorescence analysis. The A549, Beas2B, C2C12, Caco-2 and COS-7 cells (rows A-E, respectively) were fixed, permeabilized, and then stained with the L12B4 anti-CFTR Ab, followed by the appropriate secondary antibody as described in 'Materials and Methods'. Left panel, cells were stained with Cy3-conjugated secondary antibody (red). Middle panel, cells were counterstained with DAPI (blue) for nuclear staining. Right panel, shown is merge of CFTR immunostaining and DAPI. Row F, Background immunofluorescence obtained in the absence of the primary antibody.
###end p 161
###begin p 162
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 606 607 606 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 950 957 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1500 1501 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1530 1531 1528 1529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2046 2047 2044 2045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 1680 1685 <span type="species:ncbi:9606">human</span>
Effect of SRF on the activity of CArG-containing CFTR minimal promoter. (A) Schematic representation of different SRF constructs analyzed. The SRF fragments shown were cloned into the pHiv expression vector as indicated in 'Materials and Methods'. The position of the MADS box containing the DNA-binding domain and dimerization domain of SRF is depicted by black rectangle. WT SRF construct encodes a human full-length SRF open reading frame. DBD SRF construct encodes only the DNA-binding domain of SRF. DN SRF deletion construct encodes full-length SRF deleted of an essential part for the DNA binding. (B) Expression of exogenous SRF in Beas2B cells. Cells were co-transfected with the WT-pGL3 luciferase reporter plasmid (left panel) together with the empty pHiv vector, pHiv-SRF, pHiv-DBD-SRF or pHiv-DN-SRF constructs, as indicated below the bar diagram. As a positive control, 3XSRE luciferase reporter plasmid was used. In each experiment, a Renilla luciferase expression plasmid was included to normalize for transfection efficiency. For each reporter plasmid, luciferase activity (mean +/- SE) is derived from 4 to 7 different transfection experiments performed in triplicate. The errors bars indicate the standard deviations. The luciferase activity value 100 was assigned to the samples co-transfected with the indicated reporter plasmid and the empty pHiv expression vector. Statistical significance is referred to differences with the activity obtained with empty expression vector. *, P < 0.05 versus WT or 3XSRE. (C) Effects of SRF siRNA on CFTR promoter activity and expression in Beas2B epithelial cells. Left panel: Beas2B cells were co-transfected with either human control siRNA vector or plasmid encoding SRF siRNA as indicated. Forty-eight hours following transfection, total proteins were harvested and analyzed by western blotting. Densitometric analysis showed a substantial decrease of endogenous SRF. Right panel: the luciferase activity value 100 was assigned to the samples co-transfected with the control siRNA. *, P < 0.05 versus WT or 3XSRE.
###end p 162
###begin p 163
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 356 357 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 620 627 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firefly</italic>
###xml 679 686 679 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The CFTR-CArG-like element is not sufficient for basal transcriptional activity in Beas2B cells. (A) EMSA analysis with nuclear extracts from SRF protein-enriched Beas2B cells using mutated labeled oligonucleotide probes (sequences listed in Table 2). Ab against SRF was included as indicated (lane 10). The arrow SS indicates the supershifted complexes. (B) Basal transcriptional activity of CArG variants of the CFTR promoter. Luciferase activity obtained with the WT-pGL3 luciferase construct was defined as 100%, and relative luciferase activities from mutant constructs are expressed as a percentage of this value. Firefly luciferase activity was normalized with respect to Renilla luciferase activity. The errors bars indicate the standard deviations. *, P < 0.05 versus WT.
###end p 163
###begin p 164
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 457 458 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 803 804 799 800 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 911 915 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 958 962 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1390 1391 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Functional interplay between SRF and YY1. (A) YY1 binding to CFTR-CArG elements. Nuclear extracts from Beas2B cells were incubated with 32P-labelled oligonucleotide probe containing either CArG-like (noted WT), consensus CArG box (noted C1, C3 and C4) in the presence or absence of specific antibody raised against YY1 as indicated. D2, which contain neither CArG element nor YY1 site, is included as negative control. Arrows indicate the position of YY1. (B) Mutually exclusive DNA-binding activity of YY1 versus SRF to the CFTR-CArG site. The same labeled CArG oligonucleotides that those used in panel A were incubated with YY1-transfected Beas2B nuclear extracts (5 microg) in the presence of increasing amounts of bacterial purified SRF (100-1000 ng). Arrows indicate the position of SRF and YY1. (C) Functional antagonism between SRF and YY1. Beas2B were transfected with constructs containing either the CFTR-CArG-like element (noted WT) or consensus CFTR-CArG-boxes (noted C1, C3 and C4), in the presence of SRF and/or YY1 expression vectors. Luciferase activities were normalized for transfection efficiency to the Renilla luciferase used as internal control. The luciferase activity value 100 was assigned to samples co-transfected with the indicated reporter plasmid and the empty expression vector. The mean +/- SD from at least three independent experiments is represented. *, P < 0.05 versus WT, C1, C3 or C4.
###end p 164
###begin p 165
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 273 274 273 274 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 518 519 518 519 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 551 555 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 636 643 636 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1039 1040 1039 1040 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 387 390 <span type="species:ncbi:9913">cow</span>
The CFTR gene untranslated regions contain multiple SRF-binding sites (CArG-boxes). (A) Schematic drawing of CFTR gene shows the exons (circles) and the location of the putative CArG boxes in the non-coding regions, including that identified in the minimal CFTR promoter. (B) The CFTR gene non-coding regions encompassing the putative CArG elements were analyzed for conservation in the cow. Species homology and positions of the conserved sequence within BAC clones are indicated, as reported in a recent work (49). (C) Comparative binding of SRF to CFTR CArG boxes. Each promoter and intronic CArG box-containing oligonucleotide (see Table 2) was radiolabeled and purified as described in 'Materials and Methods'. Upper panel, binding reaction was performed with bacterially expressed SRF. Ab against SRF was included as indicated. Arrow indicates specific DNA-SRF complexes and SS indicates the Ab-supershifted complexes. Lower panel, EMSA analysis with nuclear extracts from Beas2B cells using mutated labeled oligonucleotide probes. (D) ChIP analysis of SRF binding to the endogenous CArG regions. Lane 1 shows amplification of target sequence in immunoprecipitated chromatin fragments with anti-SRF Ab. The target sequence encompasses a CArG element, located to -2373 bp in the minimal CFTR promoter. Lane 2 shows PCR amplification of a control sample, without Ab. Lane 3 shows amplification of 1:100 dilution samples of total input DNA for immunoprecipitation.
###end p 165
###begin p 166
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Schematic model depicting potential mechanism that might contribute to epithelial-specific regulation of the CFTR gene. In this model, arrows and bubbles marked in gray indicate multiple potential SRF-mediated regulation pathways, such as protein-protein interaction and potential induction by the Ras-related GTPases cascades. Blue and pink bubbles indicate trans-factors identified in this study that contribute to the basal CFTR transcriptional activity. Black and double arrow shows the functional antagonism between YY1 and SRF identified in this study through the CFTR-CArG-like element characterization.
###end p 166
###begin p 167
Sequences of oligonucleotides
###end p 167
###begin p 168
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aBold type indicates the restriction sites: HindIII and HincII.
###end p 168
###begin p 169
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bBold and italicized type indicates mutated nucleotides.
###end p 169
###begin p 170
Ologonuc leotides used in EMSA analysis
###end p 170
###begin p 171
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 152 161 152 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
Bold and italicized type indicates mutated nucleotides. The CArG boxes in the CFTR minimal promoter are shaded. The underlined nucleotides indicate the in silico predicted CArG elements in the non-coding regions of the CFTR gene.
###end p 171
###begin p 172
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
ac-fos consensus SRE (56).
###end p 172
###begin p 173
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b85">85</xref>
bOligonucleotide for competition assay, the GATA and E-box sequences are boxed (85).
###end p 173
###begin p 174
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
cCArG-like box located in the human minimal CFTR promoter region.
###end p 174
###begin p 175
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
dCArG-like box located in the human minimal CFTR promoter region containing the naturally occurring variant [-102T>A] (12).
###end p 175
###begin p 176
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
eConsensus CArG box with minimal CFTR promoter flanking sequences.
###end p 176
###begin p 177
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sup>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
fMutated CArG box with minimal CFTR promoter flanking sequences.
###end p 177

